In accordance with our results, previous studies in early NSCLC reported that GAL‐3 expression on tumor cells has been reported to be associated with progression, poor prognosis and recurrence after radical resection on tissue samples [61]. Here, LGALS3 is linked to non-small cell lung carcinoma.